Twelve Hundred Patients, One Weekly Shot: The Mega-Trial Testing Semaglutide for Addiction
Funded by a $13.3 million Arnold Ventures grant, researchers at the University of Pittsburgh and Allegheny County will test once-weekly semaglutide, added to standard care for 52 weeks, in up to 1,200 adults with alcohol use disorder, opioid use disorder, or both — tracking employment, housing and criminal-justice outcomes alongside substance use.
Source
Join the Recovered Life Community
here!